The human naive B cell repertoire contains distinct subclasses for a germline-targeting HIV-1 vaccine immunogen
Colin Havenar‐Daughton(VIR Biotechnology (United States)), Shane Crotty(La Jolla Institute for Immunology), Ian A. Wilson(Raigmore Hospital), Amit A. Upadhyay(Emory National Primate Research Center), Kirti Kaushik(Post Graduate Institute of Medical Education and Research), Laura Toy(Scripps Research Institute), John R. Yates(Scripps Research Institute), Jolene K. Diedrich(Scripps Research Institute), Samantha Reiss(La Jolla Institute for Immunology), Anita Sarkar(Scripps Research Institute), James C. Paulson(University of Michigan), Isaiah Deresa(La Jolla Institute for Immunology), Steven E. Bosinger(Emory University), Torben Schiffner(Scripps Research Institute), Daniel W. Kulp(The Wistar Institute), Sergey Menis(Scripps Research Institute), Grégory Seumois(La Jolla Institute for Immunology), Oleksandr Kalyuzhniy(Scripps Research Institute), William R. Schief(Scripps Research Institute), Elise Landais(Scripps Research Institute), Sonu Kumar(Scripps Research Institute), Liwei Cao(Johns Hopkins University), Xiaozhen Hu(Scripps Research Institute)
Cited by 154
Related Papers
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
|Science|2010|1.8k
Symbol Nomenclature for Graphical Representations of Glycans
|Glycobiology|2015|1.1k
Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer
|Science|2013|826